2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Neoplasms
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Spondylarthritis
1
Precancerous Conditions
1
Papillomavirus Infections
1
Neuroblastoma
1
Neoplasms by Site
1
Myelodysplastic Syndromes
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
Paclitaxel
13
pembrolizumab
8
Carboplatin
7
Surveys and Questionnaires
6
Cisplatin
6
Brachytherapy
5
Doxorubicin
4
Docetaxel
4
Pemetrexed
3
Hyperthermic Intraperitoneal Chemotherapy
3
Gemcitabine
3
FANG vaccine
3
Biopsy
3
osimertinib
2
olaparib
2
niraparib
2
durvalumab
2
adavosertib
2
Trastuzumab
2
Topotecan
2
Taxes
2
Standard of Care
2
Sentinel Lymph Node Biopsy
2
Saline Solution
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Radiation
2
Oxaliplatin
2
Nivolumab
2
Music Therapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Pregnancy Tests
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled